Boston Scientific Corporation (NYSE:BSX) is one of the best mid-cap growth stocks to buy right now. On January 16, ...

This recent drop highlights revived worries regarding the initial earnings dilution stemming from its Penumbra ...

Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between ...

What Happened? Shares of medical device company Boston Scientific (NYSE:BSX) fell 4.6% in the afternoon session after the ...

Boston Scientific stock may rebound after agreeing to buy Valencia Technologies, adding the FDA-approved eCoin ITNS device to ...

Delving into the details, we found 47% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we ...

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...

Fitch expects Boston Scientific to achieve double-digit top-line growth over the rating horizon, forecasting 2025 revenue of ...

Penumbra (PEN) climbs on strong Q4 results and acquisition agreement with Boston Scientific (BSX), deal valued at $14.5B.

Boston Scientific (BSX) on Thursday announced a definitive agreement to acquire Penumbra (PEN) in a cash and stock ...

It is hard to get excited after looking at Boston Scientific's (NYSE:BSX) recent performance, when its stock has declined 10% ...

Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or ...